Seok Jin Kim
Sungkyunkwan University
H-index: 58
Asia-South Korea
Top articles of Seok Jin Kim
Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies
2024/5/5
Seok Jin Kim
H-Index: 33
Sang Eun Yoon
H-Index: 3
Feasibility of Circulating Tumor DNA Analysis in Patients with Follicular Lymphoma
Cancer Research and Treatment
2024/1/16
Tumor-infiltrating T lymphocytes evaluated using digital image analysis predict the prognosis of patients with diffuse large B-cell lymphoma
Journal of Pathology and Translational Medicine
2024/1
Real-world experiences of CNS-directed chemotherapy followed by autologous stem cell transplantation for secondary CNS involvement in relapsed or refractory diffuse large B …
Frontiers in Oncology
2023/1/19
Sang Eun Yoon
H-Index: 3
Seok Jin Kim
H-Index: 33
Optimizing Circulating Tumor DNA Limits of Detection for DLBCL during First Line Therapy
Blood
2023/11/28
The impact of sMICA/sMICB on immunochemotherapy outcomes in newly diagnosed diffuse large B-cell lymphoma
Frontiers in Oncology
2023
Real-World Data of Outcome of Patients with Newly Diagnosed Bronchial-Associated Lymphoid Tissue Lymphoma: A Multi-Center Retrospective Analysis with Long-Term Survivors
Blood
2023/11/28
Sang Eun Yoon
H-Index: 3
Seok Jin Kim
H-Index: 33
Phase II Study of Lenalidomide Maintenance after Salvage Therapy for Relapsed or Refractory Peripheral T-Cell Lymphomas
Blood
2023/11/28
Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation
Frontiers in Oncology
2023
Seok Jin Kim
H-Index: 33
Sang Eun Yoon
H-Index: 3
Isatuximab and Cemiplimab in Relapsed or Refractory Extranodal Natural Killer/T-Cell Lymphoma: A Multi-Center, Open-Labeled Phase II Study (CISL2102/ICING study)
Blood
2023/11/28
Seok Jin Kim
H-Index: 33
Sang Eun Yoon
H-Index: 3
Prognostic Utility of Minimal Residual Disease (MRD) after Curative Intent Induction Therapy for DLBCL: A Prospective Real-World Ctdna Study
Blood
2023/11/28
Outcomes in refractory diffuse large B-cell lymphoma: results from two prospective Korean cohorts
Blood, The Journal of the American Society of Hematology
2017/10/19
A new prognostic index for extranodal natural killer/T-cell lymphoma: incorporation of serum β-2 microglobulin to PINK
Cancer Research and Treatment: Official Journal of Korean Cancer Association
2023/1
Phase 3 SELENE study: ibrutinib plus BR/R-CHOP in previously treated patients with follicular or marginal zone lymphoma
Blood Advances
2023/11/28
Differences in mutational signature of diffuse large B‐cell lymphomas according to the primary organ
Cancer Medicine
2023/10
Sang Eun Yoon
H-Index: 3
Seok Jin Kim
H-Index: 33
Circulating Tumor DNA–Based Genotyping and Monitoring for Predicting Disease Relapses of Patients with Peripheral T-Cell Lymphomas
Cancer Research and Treatment: Official Journal of Korean Cancer Association
2023/1
Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study
Blood Cancer Journal
2023/8/18
Sohee Park
H-Index: 37
Seok Jin Kim
H-Index: 33
A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B‐cell lymphoma
Cancer Medicine
2023/8
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide …
Official journal of the American College of Gastroenterology| ACG
2023/8/1
Cilta-cel or standard care in lenalidomide-refractory multiple myeloma
New England journal of medicine
2023/7/27
